Table 2.
State of the art on laboratory hemodialysis membranes
Substrate | Modification method | Functional modifier | Protein Adhesion | Platelet adhesion/activation | Immune activation | Clotting time | Reference |
---|---|---|---|---|---|---|---|
PES | Bulk modification | Ionic liquid | BSA adsorption: 52% decreased | Platelet adhesion:95% decrease calculated from SEM picture | No significant change | [263] | |
PES | Surface modification | PEtO | BSA adsorption: 56% decreased | Low platelet adhesion as indicated by SEM | No significant change | [254] | |
PES | Surface modification | Tannic acid | Reduced BSA adsorption | Low platelet adhesion as indicated by SEM | Increased radical scavenging capacity | Prolonged clotting times and reduced blood coagulation index | [253] |
PSF | Blending modification | Resveratrol | Reduced BSA adsorption | Low platelet adhesion as indicated by SEM | Increased radical scavenging capacity, and reduced C3a and C5a generation | – | [256] |
PES | Surface modification | Chitosan and heparin | Reduced BSA adsorption as indicated by fluorescence microscope | Reduced PF4 concentration | Reduced C3a and C5a generation | Reduced TAT generation | [264] |
PES | Blending modification | Ticagrelor | Reduced platelet adhesion and P-selectin expression | Reduced IL-6, THF-α, IL-10 generation | No significant change | [265] | |
PSF | Surface modification | Sodium alginate, acrylic acid | Low protein adhesion as indicated by SEM |
Low platelet adhesion as indicated by SEM, PF4: 70% decrease |
C3a: 70% decreased, C5a: 75% decreased |
APTT: 775% prolonged, TT: 94.4% prolonged, TAT: 50% decreased |
[20] |
PAN | Surface modification | Heparin-poly(vinyl alcohol) hydrogel |
Bovine serum albumin (BSA) adsorption: 98% decreased, Flux recovery: 21% increased |
– | – |
APTT: 225% prolonged, PT: 233% prolonged, TT: 200% prolonged |
[22] |
PES | Blending/surface modification | PEGMA |
BSA adsorption: 35% decreased, Flux recovery: 20% increased |
Platelet adhesion: 50% decrease calculated from SEM picture | – | – | [266] |
PAN | Surface modification | Heparin functionalized MWCNTs/PVA | BSA adsorption: 55% decreased | Platelet adhesion: 80% decrease calculated from SEM picture |
C3a: 15% decreased, C5a: 20% decreased |
Plasma recalcification time: 123% prolonged | [267] |
PES | Bulk/blending modification | Amphiphilic zwitterionic polymer |
BSA adsorption: 85% decreased, Bovine fibrinogen (BFG) adsorption: 87.5% decreased, Flux recovery: 16% increased |
Low platelet adhesion as indicated by SEM |
C3a: 5% decreased, C5a: 5% decreased |
Plasma recalcification time: 36% prolonged | [268] |
PES | Blending/surface modification | PAA-AMPS |
BSA adsorption: 55% decreased, BFG adsorption: 70% decreased, whole blood protein adsorption: 50% decreased, Flux recovery: 7% increased |
Platelet adhesion: 80% decrease calculated from SEM picture |
C3a: 10% decreased, C5a: 5% decreased, BK: 10% decreased |
APTT: 157% prolonged, TT: 584% prolonged |
[79] |
Polyvinylidene Fluoride (PVDF) | Blending modification | Poly(ethylene glycol)-multi-walled carbon nanotubes |
BSA adsorption: 80% decreased, Flux recovery: 20% increased |
– | – | – | [269] |
PSF | Surface modification | Poly AA-HEMA | Flux recovery: 116% increased | – | – | APTT: 33% prolonged | [241] |
PSF | Blending modification | P(VP-VTES)-b-P(SSNa-VTES-AA) | – | Low platelet adhesion as indicated by SEM |
C3a: 25% decreased, C5a: 50% decreased |
APTT: 1900% prolonged, PT: 100% prolonged, TT: 80% prolonged |
[203] |
PES | Surface modification | Sulfonated sodium alginate |
BSA adsorption: 33% decreased, BFG adsorption: 50% decreased, |
Platelet adhesion: 90% decrease calculated from SEM picture | – |
APTT: 30% prolonged, PT: 10% prolonged, TT: 20% prolonged |
[270] |
PES | Bulk/surface modification | Sulphated carboxymethylcellulose |
BSA adsorption: 70% decreased, Flux recovery: 150% increased |
Low platelet adhesion as indicated by SEM | – | – | [271] |
PAN | Surface modification | Branched polyethylenimine | – | Platelet adhesion: 45% decrease calculated from SEM picture | – | Plasma recalcification time: 60% prolonged | [272] |
PES | Blending modification | GO | Flux recovery: 30% increased | Low platelet adhesion as indicated by SEM | – |
APTT: 25% prolonged, PT: 10% prolonged, TT: 10% prolonged |
[273] |
PES | Blending/surface modification | P(AA-co-HEMA)/PSSNa |
BSA adsorption: 66% decreased, BFG adsorption: 50% decreased, Flux recovery: 20% increased |
Platelet adhesion: 98% decrease calculated from SEM picture, PF4: 20% decrease |
C3a: 45% decreased, C5a: 10% decreased |
APTT: 125% prolonged, TT: 66% prolonged |
[274] |
PES | Bulk modification | Heparin-like PES |
BSA adsorption: 60% increased, BFG adsorption: 65% decreased |
PF4: 10% decrease |
C3a: 16% decreased, C5a: 33% decreased |
APTT: 225% prolonged, TT: 40% prolonged |
[100] |
PSF | Surface modification | Sulfonated hydroxypropyl chitosan | BSA adsorption: 85% decreased | Low platelet adhesion as indicated by SEM | – |
Whole blood clotting time: 190% prolonged, APTT: 10% prolonged, TT: 100% prolonged |
[275] |
PES | Blending modification | Heparin-mimicking polyurethanes |
BSA adsorption: 50% increased, BFG adsorption: 40% decreased |
Platelet adhesion: 95% decrease calculated from SEM picture |
C3a: 45% decreased, C5a: 15% decreased |
APTT: 162% prolonged, TT: No change |
[226] |
PSF | Blending modification | Poly(vinyl pyrrolidone-co-vinyltriethoxysilane |
BSA adsorption: 60% decreased, Flux recovery: 50% increased |
Low platelet adhesion as indicated by SEM | – |
APTT: 30% prolonged, PT: 20% prolonged |
[276] |
PAN | Surface modification | Polyvinyl alcohol | BSA adsorption: 60% decreased | Low platelet adhesion as indicated by SEM |
C3a: 5% decreased, C5a: 20% decreased |
– | [277] |